Press Releases

All News
By Year:
2019
2018
2017
2016

Mar 19, 2019

DiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate Update

Mar 18, 2019

DiaMedica Therapeutics Announces Date for the Release of Full Year 2018 Results and Conference Call

Mar 12, 2019

DiaMedica Therapeutics to Attend 31st Annual ROTH Investor Conference on March 18-19, 2019

Feb 14, 2019

DiaMedica Therapeutics Doses First Patient in Phase 1b Clinical Study of DM199 in Patients with Chronic Kidney Disease

Jan 22, 2019

DiaMedica Therapeutics Announces Publication of a Paper, “Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke,” in the Journal Therapeutic Advances in Neurological Disorders

Jan 9, 2019

DiaMedica Therapeutics Announces Voluntary Delisting from TSX Venture Exchange

Jan 3, 2019

DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney Disease

Dec 7, 2018

DiaMedica Announces Pricing of Initial Public Offering and Nasdaq Listing

Nov 12, 2018

DiaMedica Therapeutics Has Applied to List its Common Shares on Nasdaq, Announces Share Consolidation

Nov 6, 2018

DiaMedica Therapeutics Announces Results From Annual General and Special Meeting of Shareholders

1
2
3
4
5
6
Next >>